About Quad Technologies
Quad Technologies is a Healthcare company based in Woburn (United States) founded in 2013, and was acquired by Bio-Techne in June 2018. Cell isolation technologies are developed using biocompatible hydrogel platforms. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include BioLife Solutions, RoosterBio and OriGene; 2 of its 3 listed competitors have raised funding.
Company details
Quad Technologies was founded in 2013 in Woburn, United States, within the biotechnology sector focused on cell isolation. A proprietary platform called QuickGel is utilized, consisting of a biocompatible and non-cytotoxic hydrogel that can be modified with antibodies and proteins. Operations center on developing tools like the MagCloudz Streptavidin Cell Separation kit, which facilitates isolation and release of cells via biotinylated antibodies.
- Headquarters Woburn, United States
- Stage Acquired
- SectorsHealthcare
- Website quadtechnologies.com
- Social LinkedIn X
- Acquired by Bio-Techne (Jun 2018)
- InvestorsBio-Techne
& 3 more
- Acquired byBio-Techne
(Jun 2018)
Funding Insights of Quad Technologies
- Total Rounds 4
- First Round $10,000
(Feb 2013)
- Investors Count 3
All 4 funding rounds of Quad Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | Series A | – | – | ||
| Feb 2015 | Series A | – | – | – | |
| Oct 2013 | $45,000 | Grant | – | – | |
| Feb 2013 | $10,000 | Grant | – | – | – |
4 investors in total: 4 institutional.
Investors in Quad Technologies
Quad Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Bio-Techne, Keswick Ventures and Sands Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| keswickventures.com | ||||
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
Early-stage entrepreneurs are accelerated through MassChallenge's program. | masschallenge.org | Boston, United States | ||
Developer of biotech reagents, instruments and clinical diagnostic products | 1981 | bio-techne.com | Minneapolis, United States |
Investor details for Quad Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Quad Technologies
4 dated milestones of Quad Technologies across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Quad Technologies is founded.
- Funding First funding round of $10K.
- Funding Latest funding round, Series A,.
- Exit Acquired by Bio-Techne.
Competitors of Quad Technologies
Quad Technologies has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of Quad Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Quad Technologies (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quad Technologies
Complete news archive for Quad Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quad Technologies
Quad Technologies was founded in 2013.
Quad Technologies is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Quad Technologies was founded in 2013 in Woburn, United States, within the biotechnology sector focused on cell isolation. A proprietary platform called QuickGel is utilized, consisting of a biocompatible and non-cytotoxic hydrogel that can be modified with antibodies and proteins. Operations center on developing tools like the MagCloudz Streptavidin Cell Separation kit, which facilitates isolation and release of cells via biotinylated antibodies.
Quad Technologies's top competitors include RoosterBio, BioLife Solutions and OriGene.
Quad Technologies has 4 investors. Key investors include Bio-Techne, Keswick Ventures, Sands Capital Ventures, and MassChallenge.
Yes. Quad Technologies was acquired by Bio-Techne in June 2018.